Compare Abbott Laboratories (ABT) vs United Parcel Service Inc (UPS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs United Parcel Service Inc — how do they compare? Abbott Laboratories trades at $95.6 (market cap $166.94B), while United Parcel Service Inc trades at $109.13 (market cap $95.17B). The key difference: Abbott Laboratories is the larger of the two by market cap, and United Parcel Service Inc pays the higher dividend (5.86%). Which is the better fit depends on your goals.
| ABT | UPS | |
|---|---|---|
Market Cap | $166.94B | $95.17B |
Sector | Health | Industrials |
52-Week High | $136.62 | $120.00 |
52-Week Low | $82.57 | $82.58 |
Enterprise Value | $193.69B | $118.03B |
Dividend Yield | 2.63% | 5.86% |
Volume | — | 2,288,643 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
UPS trades at $111.96, up 1.15% with a bullish technical signal. Recent earnings beat expectations (Q1 2026 EPS of $1.07 vs. $1.02 expected), though revenue declined to $88.66B in 2025. The company invests in healthcare logistics and AI to boost efficiency. Valuation ratios appear reasonable with P/E of 17.8 and P/S of 1.06. Analyst consensus is mixed with 42% buy ratings and a $111 price target.
Outlook: UPS faces revenue pressure but maintains solid profitability (ROE 33.41%). Strategic investments in temperature-controlled facilities and AI could drive growth. Risks include competitive threats and economic sensitivity. The stock offers stability with dividend income, but upside may be limited near the consensus target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
